Array asthma drug meets main goal in mid-stage study

[riky]

Array asthma drug meets main goal in mid-stage study

(Reuters) - Array Biopharma Inc said one of its drugs met the main goal of improving lung function in a mid-stage study among patients with mild to moderate persistent allergic asthma. Array shares rose as much as 19 percent to $6.64 â€" their highest in nearly five years â€" on Tuesday morning. Array said it was seeking a partner to develop the drug and Chief Executive Ron Squarer said there was substantial interest from key players in the field. "In theory, with a partner we may look at higher doses of the drug. ...

Source: You are not allowed to view links. Register or Login